Paclitaxel controversy to headline inaugural CX 2020 LIVE session


Join a wealth of experts and faculty from around the world for the very first session of CX 2020 LIVE—the inaugural virtual Charing Cross (CX) Symposium—titled ‘Paclitaxel-coated Device Consensus Update’.

Renowned interventional radiologist Andrew Holden (Auckland, New Zealand), who is a member of the CX Peripheral Arterial Executive Board, welcomes the […]